Nature. 2006 Oct 19;443(7113):768-73.

A network dysfunction perspective on neurodegenerative diseases.

Source

Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, California 94158, USA.

Abstract

Patients with Alzheimer's disease or other neurodegenerative disorders show remarkable fluctuations in neurological functions, even during the same day. These fluctuations cannot be caused by sudden loss or gain of nerve cells. Instead, it is likely that they reflect variations in the activity of neural networks and, perhaps, chronic intoxication by abnormal proteins that the brain is temporarily able to overcome. These ideas have far-reaching therapeutic implications.

PMID:: 17051202; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Degenerative Nerve Diseases - MedlinePlus Health Information

Supplemental Content

Related citations

Review The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review. [BMC Neurosci. 2008]
Review The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review.
Sanchez-Ramos J, Song S, Cao C, Arendash G. BMC Neurosci. 2008 Dec 3; 9 Suppl 2:S3. Epub 2008 Dec 3.
Review Stem cells and neurodegenerative diseases. [Sci China C Life Sci. 2008]
Review Stem cells and neurodegenerative diseases.
Hou L, Hong T. Sci China C Life Sci. 2008 Apr; 51(4):287-94. Epub 2008 Mar 27.
Neurodegenerative disorders and their treatment. [Drug News Perspect. 2007]
Neurodegenerative disorders and their treatment.
Karran E, Palmer AM. Drug News Perspect. 2007 Jul-Aug; 20(6):407-12.
Review Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease. [J Neurochem. 2007]
Review Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease.
Spires TL, Hannan AJ. J Neurochem. 2007 Feb; 100(4):874-82. Epub 2007 Jan 8.
Review Proteopathy: the next therapeutic frontier? [Curr Opin Investig Drugs. 2002]
Review Proteopathy: the next therapeutic frontier?
Walker LC, LeVine H 3rd. Curr Opin Investig Drugs. 2002 May; 3(5):782-7.

See reviews... See all...

Cited by 41 PubMed Central articles

Neurons on a chip - toward high throughput network and pharmacology investigations. [Front Pharmacol. 2011]
Neurons on a chip - toward high throughput network and pharmacology investigations.
Nagarah JM. Front Pharmacol. 2011; 2:74. Epub 2011 Nov 23.
From understanding cellular function to novel drug discovery: the role of planar patch-clamp array chip technology. [Front Pharmacol. 2011]
From understanding cellular function to novel drug discovery: the role of planar patch-clamp array chip technology.
Py C, Martina M, Diaz-Quijada GA, Luk CC, Martinez D, Denhoff MW, Charrier A, Comas T, Monette R, Krantis A, et al. Front Pharmacol. 2011; 2:51. Epub 2011 Oct 3.
Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. [Future Neurol. 2010]
Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.
Miller BR, Bezprozvanny I. Future Neurol. 2010 Sep; 5(5):735-756.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A network dysfunction perspective on neurodegenerative diseases.
A network dysfunction perspective on neurodegenerative diseases.
Nature. 2006 Oct 19 ;443(7113):768-73.

PubMed
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosa...
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.
Cancer Cell. 2008 Nov 4 ;14(5):369-81.

PubMed
Epilepsy and cognitive impairments in Alzheimer disease.
Epilepsy and cognitive impairments in Alzheimer disease.
Arch Neurol. 2009 Apr ;66(4):435-40. Epub 2009 Feb 9 .

PubMed
Health reforms in Pakistan--configuring health beyond the health sector.
Health reforms in Pakistan--configuring health beyond the health sector.
J Pak Med Assoc. 2006 Dec ;56(12 Suppl 4):S120-35.

PubMed
Evidence from research and its implications for health reforms in Pakistan: the ...
Evidence from research and its implications for health reforms in Pakistan: the Gateway Paper perspective.
J Pak Med Assoc. 2006 Dec ;56(12 Suppl 4):S112-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: